Our Team
ASC Therapeutics is an independent, fully incorporated biopharmaceutical company with dedicated scientists and industry veterans with a strong belief in gene and cell therapy, the future for treating rare disease.
The company leverages over 12 years of experience by Applied StemCell, Inc., a separate entity, focused on developing and improving gene editing and stem cell technologies.


Ruhong Jiang, PhD
Co-founder, President and CEO
- 20+ years industrial experience (US and China) in research tool, molecular diagnostic product and drug development, and corporate development
- General manager of MicuRx, China
- Founding members of two biotech companies
- Co-founder of two biotech companies






Gary Potter
SENIOR VP, GLOBAL OPERATIONS
- 20+ years of GMP manufacturing experience in gene therapies, cell culture manufacturing and whole cell anti-cancer therapies
- Facility design, start-up, engineering, validation, and operations
- Global manufacturing in the US and Europe at uniQure
Steve Zhang, PhD
VP, Gene & Cell Therapy
- 20+ years of biotech experience developing novel technologies and genetic therapies
- Former associate director at Sangamo Therapeutics
- Inventor of multiple patents in the field of gene therapy, gene regulation and genome editing
- Ph.D. in molecular genetics from Washington University
Zoya Gluzman-Poltorak, PhD, MBA
VP, THERAPEUTIC DEVELOPMENT
- Over 20 years of executive-level leadership experience in cutting-edge biotechnology companies, advancing several cell-, gene- and protein-based products from idea through pre-clinical into clinical development.
- Pioneered ASC Therapeutics Division to advance AAV gene therapy, genome editing and cell therapy pipeline from early development through 3 pre-IND meetings toward IND submissions, managing preclinical, regulatory, and analytical methods development.
- PhD in Cell Biology and Genetic Engineering and MBA from the Technion, Israel Institute of Technology.
Terry Brown
SENIOR DIRECTOR, QUALITY
- More than 25 years of experience in QA/QC pharmaceutical/biotech industry; Quality System establishment and management
- Experienced in auditing for GLPs, GCPs, GMPs, and hosting regulatory inspections
- ISO 9001 certification, support of regulatory submissions: IND, ELA, PLA, BLA, DMF, and NDA.
Jeremy Watts
DIRECTOR, CORPORATE PROGRAM MANAGEMENT
- 10+ years’ experience in all aspects of biomanufacturing and CMC product development
- Program and project management, commercial operations, engineering, validation, operations for large and small-scale manufacturing facilities
- B.S. in Biological Systems Engineering from the University of California, Davis and M.S. in Engineering Management from Pennsylvania State University
Weicheng Wu, PhD, RAC
VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS
- 20+ years of experience in biomedical research and regulatory affairs (US, EU, Canada, China)
- Broad regulatory experience supporting development and commercialization of biologics, drugs, molecular diagnostics and medical devices
- Successfully submitted several INDs/CTAs for new biologics and drugs